SCHEMBL4958876

SCHEMBL4958876

Clc1ccc(Nc2nc(-c3ccccc3)cs2)cc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.69
KMT2A Q03164 6/20 0.69
SMN1; SMN2 Q16637 5/20 0.69
MAPT P10636 5/20 0.69
LMNA P02545 2/20 0.69
ALOX5 P09917 5/20 0.64
CYP1A1 P04798 3/20 0.64
CYP1A2 P05177 3/20 0.64
CYP1B1 Q16678 3/20 0.64
VCP P55072 2/20 0.64
AMY1A P0DUB6 1/20 0.63
PTGS2 P35354 2/20 0.61
GAA P10253 2/20 0.60
ALDH1A1 P00352 1/20 0.60
RAB9A P51151 4/20 0.59
CFTR P13569 1/20 0.59
NFKB1 P19838 1/20 0.59
RECQL P46063 1/20 0.59
NFKB2 Q00653 1/20 0.59
RELA Q04206 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6156291 0.97 MEN1 (0.66) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL14458492 0.89 PTGS2 (0.76) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL208192 0.89 ALOX5 (0.72) MEN1KMT2AMAPTALOX5VCP
SCHEMBL1885333 0.89 ESR1 (0.72) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL205976 0.88 ALOX5 (0.80) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL12297226 0.87 MEN1 (0.69) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL205448 0.86 ALOX5 (0.65) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL26126062 0.86 ALOX5 (0.85) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL12297742 0.85 MEN1 (0.80) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL12298053 0.85 MEN1 (0.73) MEN1KMT2ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192595-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME Arkansas State University - Jonesboro (US) 2023-10-05 WO disclosed
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES IMPINJ, INC. 2008-08-21 US disclosed
US-7381736-B2 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. (US) 2008-06-03 US disclosed
EP-1841749-A1 DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES Metabasis Therapeutics, Inc. (US) 2007-10-10 EP disclosed
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2006-08-31 US disclosed
WO-2006028970-A1 DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES CENGENT THERAPEUTICS, INC. (US) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases PTPN1, PTPN5, PTPN18 MEN1 2838/4885KMT2A 1604/4885SMN1; SMN2 4199/4885
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES PTPN1, PTPN5, PTPN18 MEN1 2838/4885KMT2A 1604/4885SMN1; SMN2 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.